These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 23293020)

  • 1. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
    Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
    J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.
    Youmans KL; Tai LM; Nwabuisi-Heath E; Jungbauer L; Kanekiyo T; Gan M; Kim J; Eimer WA; Estus S; Rebeck GW; Weeber EJ; Bu G; Yu C; Ladu MJ
    J Biol Chem; 2012 Dec; 287(50):41774-86. PubMed ID: 23060451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
    Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
    Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3.
    Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L
    Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.
    Tai LM; Mehra S; Shete V; Estus S; Rebeck GW; Bu G; LaDu MJ
    Mol Neurodegener; 2014 Jan; 9():2. PubMed ID: 24386905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
    Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
    J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
    Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
    J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
    Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
    Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
    Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
    Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
    Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
    Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
    Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
    Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
    Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
    J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice.
    Chan ES; Chen C; Cole GM; Wong BS
    Sci Rep; 2015 Sep; 5():13842. PubMed ID: 26346625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.